Interview: CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI)

Interview: CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI)

CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI), rejoins Stock Day to discuss in detail recent strategic alliance with MJ Biopharm, their insulin mouth rinse solution, and how it will help in the treatment of diabetes worldwide.

CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI) – March ’19 update

The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.

Close Menu

SIGN UP FOR THE EMAIL NEWSLETTER

The latest in micro-cap news and podcasts, straight to your inbox.

We won't ever spam!